One Mother Asks: Has the FDA Torpedoed the 'Right to Try'?

<![CDATA[In 2018, Congress finally passed one of Donald Trump's priorities in his first campaign – the Right to Try Act. Trump had picked up on frustration with an overly bureaucratic Food and Drug Administration and its response to terminal or near-terminal diseases. While the process used by the FDA for drug approvals emphasizes safety, it can take a decade or more to get approvals, especially for rarer diseases that make multiple double-blind studies difficult to complete. Trump's legislation allowed patients and families access to drugs in the study process and/or pending approval while waiving the risks of experimental treatment. ]]>